- Home
- MFH vs CMRX Comparison
MFH vs CMRX Comparison
Compare MFH & CMRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MFH
- CMRX
- Stock Information
- Founded
- MFH 2011
- CMRX 2000
- Country
- MFH United States
- CMRX United States
- Employees
- MFH N/A
- CMRX N/A
- Industry
- MFH Finance: Consumer Services
- CMRX Biotechnology: Pharmaceutical Preparations
- Sector
- MFH Finance
- CMRX Health Care
- Exchange
- MFH Nasdaq
- CMRX Nasdaq
- Market Cap
- MFH 394.2M
- CMRX 394.1M
- IPO Year
- MFH N/A
- CMRX 2013
- Fundamental
- Price
- MFH $4.86
- CMRX $8.47
- Analyst Decision
- MFH
- CMRX Hold
- Analyst Count
- MFH 0
- CMRX 4
- Target Price
- MFH N/A
- CMRX $8.51
- AVG Volume (30 Days)
- MFH 96.6K
- CMRX 8.8M
- Earning Date
- MFH 04-21-2025
- CMRX 04-30-2025
- Dividend Yield
- MFH N/A
- CMRX N/A
- EPS Growth
- MFH N/A
- CMRX N/A
- EPS
- MFH N/A
- CMRX N/A
- Revenue
- MFH $716,863.00
- CMRX $159,000.00
- Revenue This Year
- MFH N/A
- CMRX N/A
- Revenue Next Year
- MFH N/A
- CMRX $2,324.80
- P/E Ratio
- MFH N/A
- CMRX N/A
- Revenue Growth
- MFH 119.50
- CMRX N/A
- 52 Week Low
- MFH $1.03
- CMRX $0.75
- 52 Week High
- MFH $8.86
- CMRX $8.48
- Technical
- Relative Strength Index (RSI)
- MFH 33.63
- CMRX 84.52
- Support Level
- MFH $4.49
- CMRX $8.41
- Resistance Level
- MFH $5.13
- CMRX $8.47
- Average True Range (ATR)
- MFH 0.57
- CMRX 0.24
- MACD
- MFH -0.12
- CMRX 0.28
- Stochastic Oscillator
- MFH 14.86
- CMRX 99.75
About MFH Mercurity Fintech Holding Inc.
Mercurity Fintech Holding Inc is a digital fintech company powered by blockchain technology. The company's scope of business includes digital asset trading, asset digitization, cross-border remittance, and other services, providing compliant, professional, and efficient digital financial services to its customers. The group is also engaged in Bitcoin mining, digital currency investment, and trading, continuing its expansion to online and traditional brokerage services and other related fields.
About CMRX Chimerix Inc.
Chimerix Inc. is a biopharmaceutical company based in the United States that engages in the research, development, and commercialization of medicines. Its portfolio includes treatment for acute myeloid leukemia (or AML) and antiviral treatment for smallpox. The company generates revenue through revenue related to non-refundable upfront fees, royalties and milestone payments earned under license agreements, also by royalty revenue related to sales of TEMBEXA made by Emergent after the Asset Sale. The company operates only in one business segment namely pharmaceuticals.